Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Trial · NCT01275677
Adverse events164
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 164
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Alopecia | Skin and subcutaneous tissue disorders | Arm I (Chemotherapy) | 633 | 1,615 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | Arm II (Chemotherapy, Trastuzumab) | 653 | 1,625 | |
| other | Anemia | Blood and lymphatic system disorders | Arm I (Chemotherapy) | 222 | 1,615 | |
| other | Anemia | Blood and lymphatic system disorders | Arm II (Chemotherapy, Trastuzumab) | 327 | 1,625 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Arm I (Chemotherapy) | 161 | 1,615 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Arm II (Chemotherapy, Trastuzumab) | 233 | 1,625 | |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Arm I (Chemotherapy) | 228 | 1,615 | |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Arm II (Chemotherapy, Trastuzumab) | 221 | 1,625 | |
| other | Constipation | Gastrointestinal disorders | Arm I (Chemotherapy) | 135 | 1,615 | |
| other | Constipation | Gastrointestinal disorders | Arm II (Chemotherapy, Trastuzumab) | 124 | 1,625 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Arm I (Chemotherapy) | 80 | 1,615 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Arm II (Chemotherapy, Trastuzumab) | 136 | 1,625 | |
| other | Diarrhea | Gastrointestinal disorders | Arm I (Chemotherapy) | 228 | 1,615 | |
| other | Diarrhea | Gastrointestinal disorders | Arm II (Chemotherapy, Trastuzumab) | 324 | 1,625 | |
| other | Fatigue | General disorders | Arm I (Chemotherapy) | 629 | 1,615 | |
| other | Fatigue | General disorders | Arm II (Chemotherapy, Trastuzumab) | 644 | 1,625 | |
| other | Headache | Nervous system disorders | Arm I (Chemotherapy) | 164 | 1,615 | |
| other | Headache | Nervous system disorders | Arm II (Chemotherapy, Trastuzumab) | 187 | 1,625 | |
| other | Hypertension | Vascular disorders | Arm I (Chemotherapy) | 103 | 1,615 | |
| other | Hypertension | Vascular disorders | Arm II (Chemotherapy, Trastuzumab) | 196 | 1,625 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01275677/events